-
Product Insights
NewNet Present Value Model: F. Hoffmann-La Roche Ltd’s Tominersen
Empower your strategies with our Net Present Value Model: F. Hoffmann-La Roche Ltd's Tominersen report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Left Atrial Appendage Closure Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Left Atrial Appendage Closure Devices Pipeline Market Report Overview Left atrial appendage closure device prevents blood flow into the left atrial appendage, preventing blood clotting or pooling. It consists of left atrial appendage implanted occlusion devices and left atrial appendage ligation devices. One unit refers to one left atrial appendage closure device. The left atrial appendage closure devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development....
-
Product Insights
PTCA Drug Coated Balloon (DCB) Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Report Overview A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries. The PTCA Drug Coated Balloon (DCB) Catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed...
-
Sector Analysis
PTA Balloon Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
PTA Balloon Catheters Market Report Overview The PTA balloon catheters market size was valued at $2.03 billion in 2023 and will grow at a CAGR of more than 4% from 2023 to 2033. The aging population, the high prevalence of the disease in developed countries, and the development of new and improved diagnostic modalities have contributed to increased treatment rates using minimally invasive techniques, such as angioplasty and stenting. These minimally invasive procedures are used to open narrowed and occluded...
-
Product Insights
Transcatheter Mitral Valve Implantation (TMVI) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Transcatheter Mitral Valve Implantation (TMVI) Pipeline Market Report Overview The transcatheter heart valve is an artificial heart valve made up of natural tissue surrounded by a flexible mesh frame known as stent. All the components are placed in a long narrow tube known as a catheter which is then inserted into a large blood vessel in the groin area or through a small incision in chest. The transcatheter mitral valve implantation (TMVI) pipeline market research report provides a comprehensive understanding...
-
Product Insights
NewCardiac Valve Repair Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Valve Repair Devices Pipeline Market Report Overview Cardiac valve repair devices are used in Open-Heart surgery to repair the malfunctioning of valves. Only mitral valve repair has been covered under this segment. Annuloplasty is a technique used to repair an enlarged annulus. This annuloplasty device makes the opening of the valve smaller and provides support to the valve so it can close more tightly. One unit refers to One cardiac valve repair device. The Cardiac Valve Repair Devices pipeline...
-
Sector Analysis
Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Coronary Stents Market Overview The coronary stents market size was valued at $4.37 billion in 2023. The market will grow at a CAGR of less than 1% during 2023-2033. Factors such as rapidly changing lifestyles and growing unhealthy diets are leading to increased risk of coronary heart disease, which will drive the market growth in coming years. A coronary stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pucotenlimab in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pucotenlimab in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pucotenlimab in Non-Small Cell Lung Cancer Drug Details: Pucotenlimab (Puyouheng)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Orelabrutinib in Relapsed Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Orelabrutinib in Relapsed Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Orelabrutinib in Relapsed Chronic Lymphocytic Leukemia (CLL) Drug Details:...